Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by vinoveritason Oct 28, 2020 9:54am
85 Views
Post# 31794845

RE:RE:RE:RE:RE:RE:40 pennies CAD for the company contributing the most content

RE:RE:RE:RE:RE:RE:40 pennies CAD for the company contributing the most contentI'm not saying they will start marketing. Not saying they won't. I have no clue. I'm equally frustrated and disappointed.

All I am saying is that "if" a company was complicit in manipulation and they stopped being so, marketing would make a difference.

In Spectral's case, the only thing I know is that something doesn't smell right.
<< Previous
Bullboard Posts
Next >>